Clinical Application of the COPD Assessment Test: Longitudinal Data From the COPD History Assessment in Spain (CHAIN) Cohort
Ver/ Abrir
Impacto
Scholar |
Otros documentos de la autoría: Torres, Juan P. de; Marin, Jose M.; Martinez-Gonzalez, Cristina; Lucas-Ramos, Pilar de; Mir-Viladrich, Isabel; Cosio, Borja; Peces-Barba, Germán; Calle-Rubio, Miryam; Solanes-García, Ingrid; Agüero Balbin, Ramón; Diego-Damia, Alfredo de; Feu-Collado, Nuria; Alfageme Michavila, Inmaculada; Irigaray, Rosa; Balcells, Eva; Llunell Casanovas, Antònia; Galdiz Iturri, Juan Bautista; Marín Royo, Margarita; Soler-Cataluña, Juan J.; Lopez-Campos, Jose Luis; Soriano, Joan B.; Casanova, Ciro
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONMetadatos
Título
Clinical Application of the COPD Assessment Test: Longitudinal Data From the COPD History Assessment in Spain (CHAIN) CohortAutoría
Fecha de publicación
2014-07Editor
Elsevier; American College of Chest Physicians (ACCP)ISSN
0012-3692Cita bibliográfica
DE TORRES, Juan P., et al. Clinical application of the COPD assessment test: longitudinal data from the COPD History Assessment in Spain (CHAIN) cohort. CHEST Journal, 2014, vol. 146, no 1, p. 111-122Tipo de documento
info:eu-repo/semantics/articleVersión de la editorial
http://journal.publications.chestnet.org/article.aspx?articleid=1830041Versión
info:eu-repo/semantics/acceptedVersionPalabras clave / Materias
Resumen
OBJECTIVE: The COPD Assessment Test (CAT) has been proposed for assessing health status in COPD, but little is known about its longitudinal changes. The objective of this study was to evaluate 1-year CAT variability ... [+]
OBJECTIVE: The COPD Assessment Test (CAT) has been proposed for assessing health status in COPD, but little is known about its longitudinal changes. The objective of this study was to evaluate 1-year CAT variability in patients with stable COPD and to relate its variations to changes in other disease markers. METHODS: We evaluated the following variables in smokers with and without COPD at baseline and aft er 1 year: CAT score, age, sex, smoking status, pack-year history, BMI, modified Medical Research Council (mMRC) scale, 6-min walk distance (6MWD), lung function, BODE (BMI, obstruction, dyspnea, exercise capacity) index, hospital admissions, Hospital and Depression Scale, and the Charlson comorbidity index. In patients with COPD, we explored the association of CAT scores and 1-year changes in the studied parameters. R ESULTS: A total of 824 smokers with COPD and 126 without COPD were evaluated at baseline and 441 smokers with COPD and 66 without COPD 1 year later. At 1 year, CAT scores for patients with COPD were similar ( ± 4 points) in 56%, higher in 27%, and lower in 17%. Of note, mMRC scale scores were similar ( ± 1 point) in 46% of patients, worse in 36%, and better in 18% at 1 year. One-year CAT changes were best predicted by changes in mMRC scale scores ( β -coefficient, 0.47; P<, .001). Similar results were found for CAT and mMRC scale score in smokers without COPD. CONCLUSIONS: One-year longitudinal data show variability in CAT scores among patients with stable COPD similar to mMRC scale score, which is the best predictor of 1-year CAT changes. Further longitudinal studies should confirm long-term CAT variability and its clinical applicability. © 2014 AMERICAN COLLEGE OF CHEST PHYSICIANS. [-]
Publicado en
CHEST Journal, 2014, vol. 146, no 1Derechos de acceso
Copyright © by the American College of Chest Physicians
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/openAccess
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/openAccess
Aparece en las colecciones
- MED_Articles [632]